Emphasizing New Jersey’s successful efforts in business retention and growth, Lt. Governor Kim Guadagno today joined officials from GENEWIZ, Inc. to mark the company’s 15th anniversary during a ribbon cutting ceremony for their new 11,000 square foot administrative facility.
“New Jersey is home to the highest concentration of scientists in the United States, with more than 360 biotech companies based here in the Garden State,” said Lt. Gov. Kim Guadagno. “That’s why our Administration is committed to putting programs and policies in place that offer a nurturing environment where innovative companies like GENEWIZ can build successful businesses, create jobs and flourish globally. Congratulations to GENEWIZ on their 15th anniversary and their decision to remain and grow in New Jersey. We look forward to their continued advancements in genomic science.”
Founded by DNA researchers, Steve Sun and Amy Liao, GENEWIZ, Inc. is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, and Good Laboratory Practice (GLP) regulatory-compliant services. The company leads the industry in research sequencing and outsourcing partnerships with pharmaceutical, clinical, biotechnology, academic, and government institutions.
“In 1999, Steve and I founded GENEWIZ with the mission of contributing to the advancement of global life sciences by providing reliable, cost-efficient, scalable services. Fifteen years later, we remain committed to this mission. With over 24 Nobel Prize winners among our customers, GENEWIZ is privileged to enable our customers and partners to achieve breakthroughs in both basic and applied research,” remarked Dr. Amy Liao, President & COO, GENEWIZ, Inc. “Our goal is for GENEWIZ to be the best in the world and the best for the world. We work towards this goal every day by delivering research value for customers, personal and professional value for employees, and economic value for the community.”
The biotech company began as a start-up and is a graduate of the state’s Commercialization Center for Innovative Technologies (CCIT). CCIT provides service, support and resources for new and existing small businesses whose success will be significant to the growth and diversification of New Jersey’s economic base.
GENEWIZ, Inc. received state tax incentives that allowed the company to stay and expand administrative and laboratory operations in South Plainfield creating approximately 30 new jobs. The increased space includes a clean suite to provide services in the areas of biologic drug and cell bank characterization testing, clinical trial investigations and clinical diagnostic testing.
“We are pleased to celebrate the expansion of our global headquarters in South Plainfield as GENEWIZ turns fifteen. New Jersey is where GENEWIZ grew and developed into a global organization with laboratory and business facilities across the United States, Europe, Japan, and the Asia-Pacific region,” stated Dr. Steve Sun, CEO, GENEWIZ, Inc. “We are grateful for the support GENEWIZ has received from the state’s Business Action Center. We also appreciate the support from the biotechnology community, the Customized Training grants provided by the Department of Labor and Workforce Development (LWD), and the Business Employment Incentive Program (BEIP) grant from the Economic Development Authority (EDA) that enabled us to build this new facility in South Plainfield.”
Sun continued, “Advancements in genomics over the past fifteen years have been unprecedented, yet this is still the beginning. New Jersey is one of the top biotechnology hubs in the country, and GENEWIZ is well positioned to continue attracting top talent as we grow over the next fifteen years and beyond. GENEWIZ’s success is attributed to our dedicated and professional team, and to their commitment to delivering solid science and superior service.”Related Articles: